Total Payments
$46,677
2024 Payments
$4,582
Companies
42
Transactions
428
Medicare Patients
3,443
Medicare Billing
$413,896
Payment Breakdown by Category
Other$38,235 (81.9%)
Food & Beverage$7,449 (16.0%)
Consulting$468.00 (1.0%)
Travel$452.18 (1.0%)
Education$72.23 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $38,235 | 22 | 81.9% |
| Food and Beverage | $7,449 | 391 | 16.0% |
| Consulting Fee | $468.00 | 2 | 1.0% |
| Travel and Lodging | $452.18 | 8 | 1.0% |
| Education | $72.23 | 5 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $24,738 | 137 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $17,503 | 58 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $678.05 | 37 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $513.95 | 33 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $503.80 | 25 | $0 (2024) |
| Axsome Therapeutics, Inc. | $254.20 | 10 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $209.43 | 14 | $0 (2024) |
| Amgen Inc. | $199.92 | 10 | $0 (2024) |
| GENZYME CORPORATION | $182.07 | 11 | $0 (2023) |
| Merck Sharp & Dohme LLC | $165.55 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,582 | 52 | GlaxoSmithKline, LLC. ($3,665) |
| 2023 | $1,329 | 69 | Axsome Therapeutics, Inc. ($199.29) |
| 2022 | $1,229 | 65 | E.R. Squibb & Sons, L.L.C. ($132.51) |
| 2021 | $11,960 | 55 | GlaxoSmithKline, LLC. ($11,387) |
| 2020 | $9,242 | 31 | GlaxoSmithKline, LLC. ($8,657) |
| 2019 | $4,785 | 60 | Boehringer Ingelheim Pharmaceuticals, Inc. ($4,119) |
| 2018 | $3,438 | 46 | Boehringer Ingelheim Pharmaceuticals, Inc. ($2,945) |
| 2017 | $10,112 | 50 | Boehringer Ingelheim Pharmaceuticals, Inc. ($9,725) |
All Payment Transactions
428 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: Diabetes | ||||||
| 12/17/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $22.54 | General |
| Category: Narcoplepsy | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $25.03 | General |
| Category: Respiratory | ||||||
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.40 | General |
| Category: Cardiovascular | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.90 | General |
| Category: Cardiovascular | ||||||
| 12/10/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 11/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/06/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $25.43 | General |
| Category: Narcoplepsy | ||||||
| 10/30/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.94 | General |
| Category: Cardiovascular | ||||||
| 10/30/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $7.13 | General |
| Category: Cardiovascular | ||||||
| 10/28/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,600.00 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Travel and Lodging | Cash or cash equivalent | $24.64 | General |
| Category: RESPIRATORY | ||||||
| 10/02/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Cardiology | ||||||
| 09/24/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: IMMUNOLOGY | ||||||
| 09/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Respiratory | ||||||
| 08/27/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Cardiology | ||||||
| 08/21/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: IMMUNOLOGY | ||||||
| 08/21/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $1.85 | General |
| Category: IMMUNOLOGY | ||||||
| 08/21/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $1.57 | General |
| Category: IMMUNOLOGY | ||||||
| 08/07/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $26.98 | General |
| Category: Narcoplepsy | ||||||
| 08/06/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $31.21 | General |
| Category: Cardiology | ||||||
| 07/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $30.19 | General |
| Category: IMMUNOLOGY | ||||||
| 07/16/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Respiratory | ||||||
| 05/30/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $19.29 | General |
| Category: Narcoplepsy | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 413 | 709 | $216,521 | $66,955 |
| 2022 | 9 | 794 | 1,216 | $354,011 | $108,115 |
| 2021 | 11 | 1,136 | 1,630 | $371,634 | $143,138 |
| 2020 | 12 | 1,100 | 1,381 | $261,003 | $95,689 |
Total Patients
3,443
Total Services
4,936
Medicare Billing
$413,896
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 273 | 543 | $163,443 | $51,251 | 31.4% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 46 | 71 | $21,442 | $6,925 | 32.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 41 | 41 | $15,990 | $5,403 | 33.8% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2023 | 37 | 37 | $12,025 | $2,493 | 20.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 16 | 17 | $3,621 | $883.65 | 24.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 448 | 819 | $242,724 | $76,577 | 31.5% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 77 | 103 | $28,506 | $8,471 | 29.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 56 | 56 | $28,002 | $8,260 | 29.5% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2022 | 77 | 94 | $25,465 | $5,748 | 22.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 29 | 29 | $11,256 | $3,683 | 32.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 48 | 54 | $11,272 | $3,360 | 29.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 27 | 29 | $5,895 | $1,795 | 30.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 16 | 16 | $480.00 | $118.17 | 24.6% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 16 | 16 | $411.00 | $102.29 | 24.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 453 | 863 | $212,298 | $86,154 | 40.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 91 | 91 | $42,588 | $15,269 | 35.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 81 | 109 | $18,748 | $10,093 | 53.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 81 | 81 | $30,132 | $9,781 | 32.5% |
| 95806 | Unattended sleep study with recording of heart rate, oxygen, respiratory airflow and effort | Office | 2021 | 113 | 125 | $37,375 | $9,652 | 25.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 105 | 139 | $16,541 | $7,698 | 46.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 49 | 53 | $8,904 | $2,893 | 32.5% |
| 94664 | Demonstration and/or evaluation of patient use of aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure breathing (ippb) device | Office | 2021 | 42 | 48 | $1,872 | $653.77 | 34.9% |
| 94727 | Determination of lung volumes using gas dilution or washout | Facility | 2021 | 38 | 38 | $1,064 | $341.70 | 32.1% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Facility | 2021 | 41 | 41 | $1,230 | $318.57 | 25.9% |
| 94729 | Measurement of lung diffusing capacity | Facility | 2021 | 42 | 42 | $882.00 | $283.48 | 32.1% |
About Dr. Jay Fleitman, MD
Dr. Jay Fleitman, MD is a Internal Medicine healthcare provider based in Northampton, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1114904497.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jay Fleitman, MD has received a total of $46,677 in payments from pharmaceutical and medical device companies, with $4,582 received in 2024. These payments were reported across 428 transactions from 42 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($38,235).
As a Medicare-enrolled provider, Fleitman has provided services to 3,443 Medicare beneficiaries, totaling 4,936 services with total Medicare billing of $413,896. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Pulmonary Disease
- Location Northampton, MA
- Active Since 12/28/2005
- Last Updated 06/22/2009
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1114904497
Products in Payments
- TRELEGY ELLIPTA (Drug) $23,828
- WAKIX (Drug) $354.27
- BREO (Drug) $292.29
- DUPIXENT (Biological) $290.40
- ANORO (Drug) $282.25
- ELIQUIS (Drug) $265.96
- Sunosi (Drug) $254.20
- CAMZYOS (Drug) $211.56
- OFEV (Drug) $182.99
- ANORO ELLIPTA (Drug) $176.81
- Repatha (Biological) $172.97
- NUCALA (Biological) $158.20
- SYMBICORT (Drug) $151.35
- TEZSPIRE (Biological) $149.59
- Wakix (Drug) $149.53
- AIRSUPRA (Drug) $132.62
- Prolastin-C Liquid (Biological) $131.28
- XARELTO (Drug) $130.14
- BREZTRI (Drug) $114.09
- VYNDAQEL (Drug) $113.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Northampton
Christine Baker, Md, MD
Internal Medicine — Payments: $1,810
Internal Medicine $1,810
Iqbal Sorathia, Md, MD
Internal Medicine — Payments: $1,238
Internal Medicine $1,238
Meena Agarwala, Md, MD
Internal Medicine — Payments: $956.11
Internal Medicine $956.11
Angeles Gonzalez-Prado, Md, MD
Internal Medicine — Payments: $288.35
Internal Medicine $288.35
Dr. Winthrop Whitcomb, Md, MD
Internal Medicine — Payments: $245.22
Internal Medicine $245.22
Bruce Weinraub, Md, MD
Internal Medicine — Payments: $166.65
Internal Medicine $166.65